| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Drug-Eluting Stents | 29 | 2024 | 681 | 6.480 |
Why?
|
| Stents | 65 | 2021 | 3200 | 5.820 |
Why?
|
| Models, Cardiovascular | 31 | 2024 | 983 | 5.220 |
Why?
|
| Endothelial Cells | 41 | 2023 | 3592 | 5.060 |
Why?
|
| Coronary Vessels | 49 | 2023 | 3124 | 3.980 |
Why?
|
| Arteries | 28 | 2024 | 1126 | 3.460 |
Why?
|
| Endothelium, Vascular | 58 | 2016 | 4428 | 3.340 |
Why?
|
| Coronary Restenosis | 12 | 2021 | 396 | 3.040 |
Why?
|
| Sirolimus | 19 | 2024 | 1540 | 2.830 |
Why?
|
| Drug Delivery Systems | 28 | 2021 | 2238 | 2.540 |
Why?
|
| Tissue Scaffolds | 10 | 2023 | 951 | 2.450 |
Why?
|
| Hemodynamics | 28 | 2024 | 4199 | 2.410 |
Why?
|
| Renal Artery | 11 | 2024 | 353 | 2.390 |
Why?
|
| Angioplasty, Balloon | 17 | 2020 | 592 | 2.360 |
Why?
|
| Tunica Intima | 25 | 2018 | 459 | 2.330 |
Why?
|
| Paclitaxel | 15 | 2023 | 1735 | 2.300 |
Why?
|
| Swine | 64 | 2024 | 5997 | 2.300 |
Why?
|
| Sympathectomy | 10 | 2024 | 72 | 2.260 |
Why?
|
| Absorbable Implants | 11 | 2024 | 338 | 2.170 |
Why?
|
| Blood Vessel Prosthesis | 8 | 2019 | 957 | 2.030 |
Why?
|
| Prosthesis Design | 19 | 2024 | 2126 | 2.010 |
Why?
|
| Iliac Artery | 15 | 2018 | 344 | 1.990 |
Why?
|
| Carotid Arteries | 19 | 2016 | 943 | 1.890 |
Why?
|
| Fibroblast Growth Factor 2 | 19 | 2012 | 594 | 1.770 |
Why?
|
| Denervation | 5 | 2019 | 265 | 1.710 |
Why?
|
| Cardiovascular Agents | 10 | 2023 | 849 | 1.680 |
Why?
|
| Polymers | 19 | 2022 | 1632 | 1.670 |
Why?
|
| Muscle, Smooth, Vascular | 25 | 2013 | 1493 | 1.600 |
Why?
|
| Tomography, Optical Coherence | 12 | 2024 | 2957 | 1.590 |
Why?
|
| Cell Communication | 12 | 2023 | 1660 | 1.540 |
Why?
|
| Thrombosis | 27 | 2018 | 2956 | 1.530 |
Why?
|
| Heparin | 26 | 2018 | 1636 | 1.490 |
Why?
|
| Animals | 233 | 2024 | 169335 | 1.470 |
Why?
|
| Coated Materials, Biocompatible | 7 | 2020 | 311 | 1.440 |
Why?
|
| Aorta | 23 | 2023 | 2046 | 1.430 |
Why?
|
| Biocompatible Materials | 20 | 2024 | 1703 | 1.390 |
Why?
|
| Plaque, Atherosclerotic | 17 | 2023 | 1550 | 1.360 |
Why?
|
| Femoral Artery | 8 | 2020 | 829 | 1.330 |
Why?
|
| Pharmacokinetics | 5 | 2015 | 86 | 1.330 |
Why?
|
| Neointima | 6 | 2018 | 133 | 1.290 |
Why?
|
| Vascular Resistance | 5 | 2020 | 939 | 1.270 |
Why?
|
| Monocytes | 14 | 2023 | 2603 | 1.260 |
Why?
|
| Coronary Artery Disease | 31 | 2024 | 6569 | 1.260 |
Why?
|
| Endovascular Procedures | 7 | 2019 | 2218 | 1.250 |
Why?
|
| Blood Vessels | 11 | 2022 | 1110 | 1.230 |
Why?
|
| Tissue Adhesives | 6 | 2024 | 179 | 1.200 |
Why?
|
| Materials Testing | 10 | 2022 | 873 | 1.190 |
Why?
|
| Aortic Valve Stenosis | 7 | 2023 | 2034 | 1.180 |
Why?
|
| Dextrans | 12 | 2024 | 574 | 1.160 |
Why?
|
| Extracellular Matrix | 13 | 2018 | 1739 | 1.140 |
Why?
|
| Prosthesis Failure | 3 | 2018 | 1209 | 1.130 |
Why?
|
| Shock, Cardiogenic | 6 | 2024 | 711 | 1.110 |
Why?
|
| Stress, Mechanical | 28 | 2023 | 1680 | 1.080 |
Why?
|
| Rabbits | 34 | 2024 | 4774 | 1.080 |
Why?
|
| Kidney | 15 | 2024 | 7058 | 1.070 |
Why?
|
| Heart Ventricles | 9 | 2024 | 3840 | 1.070 |
Why?
|
| Myocytes, Smooth Muscle | 8 | 2015 | 703 | 1.040 |
Why?
|
| Hypertension | 13 | 2024 | 8617 | 1.030 |
Why?
|
| Pulsatile Flow | 7 | 2024 | 320 | 1.020 |
Why?
|
| Vascular System Injuries | 3 | 2015 | 248 | 1.020 |
Why?
|
| Hyperplasia | 25 | 2018 | 1154 | 0.990 |
Why?
|
| Heart-Assist Devices | 6 | 2024 | 1292 | 0.990 |
Why?
|
| Uremia | 4 | 2017 | 202 | 0.980 |
Why?
|
| Hemorheology | 6 | 2019 | 144 | 0.970 |
Why?
|
| Glucuronidase | 3 | 2012 | 205 | 0.960 |
Why?
|
| Norepinephrine | 5 | 2020 | 899 | 0.930 |
Why?
|
| Atherosclerosis | 14 | 2022 | 3431 | 0.920 |
Why?
|
| Models, Biological | 16 | 2019 | 9499 | 0.910 |
Why?
|
| Neovascularization, Physiologic | 9 | 2016 | 1371 | 0.900 |
Why?
|
| Liver Regeneration | 2 | 2016 | 214 | 0.890 |
Why?
|
| Hydrodynamics | 5 | 2021 | 167 | 0.890 |
Why?
|
| Coronary Circulation | 16 | 2021 | 1617 | 0.880 |
Why?
|
| Graft Occlusion, Vascular | 5 | 2012 | 538 | 0.880 |
Why?
|
| Polystyrenes | 2 | 2022 | 105 | 0.880 |
Why?
|
| Blood Flow Velocity | 13 | 2023 | 1376 | 0.860 |
Why?
|
| Cattle | 27 | 2011 | 3819 | 0.840 |
Why?
|
| Gelatin | 3 | 2012 | 231 | 0.830 |
Why?
|
| Gelatin Sponge, Absorbable | 8 | 2013 | 55 | 0.820 |
Why?
|
| Hydrogels | 7 | 2024 | 745 | 0.810 |
Why?
|
| Coronary Angiography | 17 | 2021 | 4541 | 0.800 |
Why?
|
| Cells, Cultured | 37 | 2023 | 19023 | 0.800 |
Why?
|
| Imaging, Three-Dimensional | 10 | 2023 | 4076 | 0.790 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 3 | 2020 | 395 | 0.770 |
Why?
|
| Models, Animal | 11 | 2019 | 2122 | 0.770 |
Why?
|
| Tissue Distribution | 15 | 2019 | 2298 | 0.760 |
Why?
|
| Ventricular Function, Left | 8 | 2024 | 3941 | 0.750 |
Why?
|
| Cell Division | 27 | 2005 | 4478 | 0.750 |
Why?
|
| Pharmaceutical Preparations | 9 | 2016 | 1088 | 0.750 |
Why?
|
| Carotid Artery Injuries | 6 | 2009 | 96 | 0.750 |
Why?
|
| Angioplasty | 6 | 2020 | 357 | 0.730 |
Why?
|
| Glycyrrhetinic Acid | 1 | 2020 | 15 | 0.730 |
Why?
|
| Glycyrrhiza | 1 | 2020 | 11 | 0.720 |
Why?
|
| Mineralocorticoids | 1 | 2020 | 37 | 0.720 |
Why?
|
| Cardiac Output | 2 | 2020 | 838 | 0.720 |
Why?
|
| Ventricular Pressure | 3 | 2022 | 210 | 0.710 |
Why?
|
| Catheter Ablation | 9 | 2024 | 2780 | 0.710 |
Why?
|
| Humans | 221 | 2024 | 768970 | 0.710 |
Why?
|
| Pheochromocytoma | 4 | 2009 | 328 | 0.710 |
Why?
|
| Nanomedicine | 1 | 2023 | 292 | 0.690 |
Why?
|
| Myocardial Revascularization | 4 | 2015 | 796 | 0.680 |
Why?
|
| Angioplasty, Balloon, Coronary | 10 | 2016 | 1724 | 0.670 |
Why?
|
| Rats | 48 | 2015 | 23786 | 0.670 |
Why?
|
| Peripheral Arterial Disease | 3 | 2021 | 1304 | 0.660 |
Why?
|
| Cell Transplantation | 5 | 2009 | 475 | 0.660 |
Why?
|
| Enzymes | 3 | 2006 | 254 | 0.660 |
Why?
|
| Catheterization, Peripheral | 2 | 2016 | 347 | 0.660 |
Why?
|
| Rats, Sprague-Dawley | 31 | 2015 | 8144 | 0.650 |
Why?
|
| Diffusion | 13 | 2009 | 818 | 0.650 |
Why?
|
| Heparitin Sulfate | 5 | 2000 | 224 | 0.650 |
Why?
|
| Tissue Engineering | 7 | 2023 | 1893 | 0.640 |
Why?
|
| Bioprosthesis | 4 | 2014 | 593 | 0.610 |
Why?
|
| Collagen | 6 | 2022 | 2646 | 0.610 |
Why?
|
| Delayed-Action Preparations | 14 | 2018 | 969 | 0.600 |
Why?
|
| Cell Adhesion | 12 | 2015 | 3102 | 0.600 |
Why?
|
| Smad2 Protein | 1 | 2018 | 144 | 0.580 |
Why?
|
| Alendronate | 2 | 2012 | 174 | 0.580 |
Why?
|
| Carotid Artery, Common | 5 | 2003 | 175 | 0.580 |
Why?
|
| Embolism | 2 | 2020 | 401 | 0.570 |
Why?
|
| Kinetics | 19 | 2019 | 6332 | 0.570 |
Why?
|
| Mitral Valve Insufficiency | 3 | 2020 | 1415 | 0.570 |
Why?
|
| Aortic Coarctation | 2 | 2016 | 278 | 0.560 |
Why?
|
| Adrenal Gland Neoplasms | 4 | 2009 | 735 | 0.560 |
Why?
|
| Hyperaldosteronism | 1 | 2020 | 252 | 0.560 |
Why?
|
| Catheters | 1 | 2020 | 427 | 0.550 |
Why?
|
| Computer Simulation | 21 | 2024 | 6291 | 0.540 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2018 | 306 | 0.540 |
Why?
|
| Myocardial Contraction | 9 | 2015 | 1526 | 0.520 |
Why?
|
| Cardiac Imaging Techniques | 1 | 2018 | 280 | 0.520 |
Why?
|
| Heart Auscultation | 1 | 2015 | 33 | 0.520 |
Why?
|
| Fatty Acids, Omega-3 | 2 | 2015 | 1399 | 0.520 |
Why?
|
| Sus scrofa | 9 | 2024 | 430 | 0.510 |
Why?
|
| Cardiotonic Agents | 4 | 2015 | 544 | 0.510 |
Why?
|
| Stethoscopes | 1 | 2015 | 30 | 0.500 |
Why?
|
| Blood Pressure | 10 | 2024 | 8544 | 0.500 |
Why?
|
| Thromboplastin | 3 | 2015 | 288 | 0.500 |
Why?
|
| Dendrimers | 4 | 2022 | 73 | 0.490 |
Why?
|
| Aortic Aneurysm | 2 | 2018 | 649 | 0.490 |
Why?
|
| Ultrasonography, Interventional | 11 | 2018 | 1524 | 0.490 |
Why?
|
| Hepatectomy | 2 | 2016 | 588 | 0.490 |
Why?
|
| Disease Models, Animal | 29 | 2024 | 18354 | 0.490 |
Why?
|
| Wound Healing | 9 | 2024 | 2815 | 0.490 |
Why?
|
| Equipment Failure | 2 | 2016 | 585 | 0.490 |
Why?
|
| Arterial Occlusive Diseases | 3 | 2012 | 746 | 0.480 |
Why?
|
| Lymphocyte Activation | 5 | 2022 | 5505 | 0.480 |
Why?
|
| Antineoplastic Agents, Phytogenic | 2 | 2017 | 622 | 0.480 |
Why?
|
| Biological Transport | 7 | 2017 | 2085 | 0.480 |
Why?
|
| Tumor Necrosis Factor-alpha | 8 | 2017 | 4356 | 0.480 |
Why?
|
| Electric Impedance | 1 | 2019 | 795 | 0.480 |
Why?
|
| Heart | 6 | 2024 | 4447 | 0.480 |
Why?
|
| Arteriosclerosis | 5 | 2004 | 1056 | 0.470 |
Why?
|
| Heparan Sulfate Proteoglycans | 5 | 2012 | 111 | 0.470 |
Why?
|
| Diabetes Mellitus, Experimental | 10 | 2021 | 1124 | 0.470 |
Why?
|
| Heart Valve Prosthesis | 4 | 2020 | 1468 | 0.470 |
Why?
|
| Serum | 2 | 2012 | 207 | 0.460 |
Why?
|
| Intracranial Embolism | 1 | 2016 | 189 | 0.460 |
Why?
|
| Extracorporeal Membrane Oxygenation | 5 | 2024 | 1483 | 0.460 |
Why?
|
| Models, Chemical | 3 | 2006 | 611 | 0.460 |
Why?
|
| Lactic Acid | 3 | 2012 | 1140 | 0.460 |
Why?
|
| Transforming Growth Factor beta | 6 | 2019 | 2004 | 0.460 |
Why?
|
| Endothelium | 3 | 2021 | 768 | 0.450 |
Why?
|
| Interdisciplinary Studies | 1 | 2014 | 86 | 0.450 |
Why?
|
| Foreign-Body Migration | 1 | 2016 | 220 | 0.450 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 2 | 2018 | 1232 | 0.450 |
Why?
|
| Cell Proliferation | 15 | 2022 | 10486 | 0.450 |
Why?
|
| Vasculitis | 5 | 2014 | 525 | 0.440 |
Why?
|
| Coronary Artery Bypass | 5 | 2012 | 2194 | 0.440 |
Why?
|
| Cell Adhesion Molecules | 5 | 2022 | 1614 | 0.440 |
Why?
|
| Heart Diseases | 2 | 2024 | 2819 | 0.430 |
Why?
|
| Vascular Surgical Procedures | 2 | 2021 | 1515 | 0.430 |
Why?
|
| Finite Element Analysis | 7 | 2023 | 442 | 0.430 |
Why?
|
| Coronary Thrombosis | 3 | 2012 | 440 | 0.420 |
Why?
|
| Chondroitin Sulfates | 3 | 2018 | 174 | 0.420 |
Why?
|
| Angina Pectoris | 4 | 2020 | 957 | 0.420 |
Why?
|
| Cell Movement | 10 | 2018 | 5216 | 0.410 |
Why?
|
| Blood Vessel Prosthesis Implantation | 6 | 2019 | 1459 | 0.410 |
Why?
|
| Glucose | 5 | 2013 | 4352 | 0.410 |
Why?
|
| Basement Membrane | 2 | 2018 | 348 | 0.410 |
Why?
|
| Biomedical Research | 4 | 2019 | 3463 | 0.400 |
Why?
|
| Inflammation | 16 | 2023 | 10868 | 0.400 |
Why?
|
| C-Reactive Protein | 6 | 2018 | 3859 | 0.400 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2020 | 1568 | 0.400 |
Why?
|
| Coculture Techniques | 7 | 2013 | 1342 | 0.400 |
Why?
|
| Paracrine Communication | 2 | 2011 | 278 | 0.390 |
Why?
|
| Immunity, Innate | 5 | 2015 | 3080 | 0.390 |
Why?
|
| Electrocardiography | 4 | 2011 | 6413 | 0.390 |
Why?
|
| Calcinosis | 2 | 2017 | 1479 | 0.390 |
Why?
|
| Arteriovenous Shunt, Surgical | 2 | 2007 | 291 | 0.390 |
Why?
|
| Heart Failure | 6 | 2024 | 11879 | 0.390 |
Why?
|
| Receptors, Growth Factor | 2 | 2010 | 326 | 0.390 |
Why?
|
| Glycemic Index | 1 | 2014 | 400 | 0.380 |
Why?
|
| Coronary Sinus | 3 | 2020 | 85 | 0.380 |
Why?
|
| Chemokine CCL2 | 2 | 2012 | 606 | 0.380 |
Why?
|
| Echocardiography | 5 | 2015 | 5047 | 0.380 |
Why?
|
| Swine, Miniature | 4 | 2018 | 965 | 0.380 |
Why?
|
| Medical Informatics | 1 | 2018 | 742 | 0.370 |
Why?
|
| Polyesters | 3 | 2020 | 377 | 0.370 |
Why?
|
| Dobutamine | 1 | 2011 | 116 | 0.370 |
Why?
|
| Regional Blood Flow | 5 | 2018 | 1500 | 0.360 |
Why?
|
| Epithelial Cells | 4 | 2022 | 3702 | 0.360 |
Why?
|
| Male | 91 | 2024 | 365203 | 0.360 |
Why?
|
| Mice | 36 | 2023 | 82072 | 0.360 |
Why?
|
| Social Change | 1 | 2011 | 152 | 0.350 |
Why?
|
| Shear Strength | 5 | 2016 | 160 | 0.350 |
Why?
|
| Heart Arrest | 2 | 2011 | 1515 | 0.350 |
Why?
|
| Microvessels | 3 | 2016 | 586 | 0.350 |
Why?
|
| Angiopoietin-1 | 1 | 2011 | 134 | 0.350 |
Why?
|
| Fluorescein-5-isothiocyanate | 2 | 2009 | 222 | 0.350 |
Why?
|
| Ribosomal Protein S6 | 1 | 2010 | 70 | 0.350 |
Why?
|
| Vascular Diseases | 7 | 2009 | 1163 | 0.350 |
Why?
|
| Receptor, TIE-2 | 1 | 2011 | 183 | 0.350 |
Why?
|
| Prostheses and Implants | 4 | 2022 | 1279 | 0.350 |
Why?
|
| Dose-Response Relationship, Drug | 14 | 2019 | 10765 | 0.340 |
Why?
|
| Stroke Volume | 5 | 2020 | 5622 | 0.340 |
Why?
|
| Diabetic Angiopathies | 3 | 2012 | 806 | 0.340 |
Why?
|
| Matrix Metalloproteinase 2 | 3 | 2010 | 462 | 0.340 |
Why?
|
| Cytoskeleton | 2 | 2012 | 1179 | 0.340 |
Why?
|
| Proteoglycans | 4 | 2000 | 809 | 0.330 |
Why?
|
| Pancreas, Artificial | 1 | 2010 | 54 | 0.330 |
Why?
|
| Treatment Outcome | 28 | 2024 | 65480 | 0.330 |
Why?
|
| Solubility | 5 | 2019 | 1087 | 0.330 |
Why?
|
| Ventricular Septal Rupture | 1 | 2009 | 17 | 0.320 |
Why?
|
| Weight-Bearing | 2 | 2009 | 534 | 0.320 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2011 | 694 | 0.320 |
Why?
|
| Industry | 1 | 2011 | 362 | 0.320 |
Why?
|
| Reperfusion Injury | 1 | 2016 | 1036 | 0.320 |
Why?
|
| Oligonucleotides, Antisense | 6 | 1997 | 461 | 0.320 |
Why?
|
| Viscoelastic Substances | 1 | 2008 | 21 | 0.320 |
Why?
|
| Th2 Cells | 2 | 2016 | 1079 | 0.320 |
Why?
|
| Fibroblast Growth Factors | 3 | 2009 | 873 | 0.320 |
Why?
|
| Anticoagulants | 10 | 2018 | 4850 | 0.320 |
Why?
|
| Science | 1 | 2011 | 236 | 0.320 |
Why?
|
| Time Factors | 26 | 2024 | 40261 | 0.310 |
Why?
|
| Hypothermia, Induced | 2 | 2011 | 756 | 0.310 |
Why?
|
| Sympathetic Nervous System | 3 | 2023 | 521 | 0.310 |
Why?
|
| Proto-Oncogene Proteins c-met | 2 | 2010 | 567 | 0.310 |
Why?
|
| Apoptosis | 7 | 2018 | 9527 | 0.310 |
Why?
|
| Phospholipase C beta | 1 | 2008 | 49 | 0.310 |
Why?
|
| Isometric Contraction | 1 | 2009 | 150 | 0.310 |
Why?
|
| Cardiology | 2 | 2018 | 1701 | 0.310 |
Why?
|
| Hyperlipidemias | 2 | 2010 | 773 | 0.300 |
Why?
|
| Polytetrafluoroethylene | 2 | 2000 | 245 | 0.300 |
Why?
|
| Polyglycolic Acid | 3 | 2023 | 408 | 0.300 |
Why?
|
| Kidney Failure, Chronic | 3 | 2021 | 2493 | 0.300 |
Why?
|
| Immunosuppressive Agents | 4 | 2016 | 4207 | 0.300 |
Why?
|
| Protein Biosynthesis | 1 | 2015 | 2094 | 0.290 |
Why?
|
| Cardiovascular Diseases | 7 | 2023 | 15661 | 0.290 |
Why?
|
| Drug Implants | 6 | 2004 | 230 | 0.290 |
Why?
|
| Signal Transduction | 13 | 2021 | 23653 | 0.290 |
Why?
|
| History, 18th Century | 3 | 2016 | 206 | 0.290 |
Why?
|
| Growth Substances | 2 | 2008 | 760 | 0.290 |
Why?
|
| Liver | 5 | 2022 | 7578 | 0.290 |
Why?
|
| Aldehydes | 1 | 2008 | 170 | 0.290 |
Why?
|
| Equipment Design | 13 | 2018 | 3530 | 0.290 |
Why?
|
| Connective Tissue | 2 | 2007 | 425 | 0.290 |
Why?
|
| Transplantation, Homologous | 6 | 2022 | 4835 | 0.280 |
Why?
|
| Pressure | 5 | 2019 | 1172 | 0.280 |
Why?
|
| Polyethylene Glycols | 6 | 2022 | 1197 | 0.280 |
Why?
|
| Research Personnel | 1 | 2012 | 590 | 0.280 |
Why?
|
| Culture Media, Conditioned | 6 | 2016 | 521 | 0.280 |
Why?
|
| Neovascularization, Pathologic | 6 | 2013 | 2634 | 0.280 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2018 | 1811 | 0.280 |
Why?
|
| Antibody Formation | 3 | 2008 | 1393 | 0.280 |
Why?
|
| Body Temperature | 1 | 2010 | 781 | 0.270 |
Why?
|
| Epinephrine | 3 | 2015 | 794 | 0.270 |
Why?
|
| Liver Diseases | 1 | 2015 | 1305 | 0.270 |
Why?
|
| Organ Specificity | 2 | 2012 | 1970 | 0.270 |
Why?
|
| Computational Biology | 1 | 2018 | 3562 | 0.270 |
Why?
|
| Immunity, Cellular | 3 | 2008 | 1560 | 0.260 |
Why?
|
| Jugular Veins | 1 | 2007 | 211 | 0.260 |
Why?
|
| Receptors, Cell Surface | 3 | 2016 | 2820 | 0.260 |
Why?
|
| Coronary Disease | 7 | 2000 | 5919 | 0.260 |
Why?
|
| Algorithms | 11 | 2021 | 14201 | 0.260 |
Why?
|
| Diabetes Mellitus | 3 | 2014 | 5892 | 0.260 |
Why?
|
| Microcirculation | 3 | 2009 | 1281 | 0.260 |
Why?
|
| History, 19th Century | 3 | 2016 | 715 | 0.260 |
Why?
|
| Bronchi | 1 | 2010 | 850 | 0.250 |
Why?
|
| Aortography | 2 | 2018 | 422 | 0.250 |
Why?
|
| Clinical Trials as Topic | 5 | 2017 | 8055 | 0.250 |
Why?
|
| Perfusion | 5 | 2019 | 1402 | 0.250 |
Why?
|
| Cell Culture Techniques | 5 | 2016 | 1667 | 0.250 |
Why?
|
| Protamines | 2 | 1997 | 112 | 0.250 |
Why?
|
| Blood Circulation | 1 | 2006 | 248 | 0.250 |
Why?
|
| Stromal Cells | 1 | 2011 | 1337 | 0.240 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2016 | 1658 | 0.240 |
Why?
|
| Mechanotransduction, Cellular | 2 | 2008 | 542 | 0.240 |
Why?
|
| Graft Rejection | 4 | 2014 | 4492 | 0.240 |
Why?
|
| Phosphorylation | 8 | 2018 | 8317 | 0.240 |
Why?
|
| Cell Membrane Permeability | 1 | 2007 | 573 | 0.240 |
Why?
|
| Neoplasm Metastasis | 2 | 2013 | 4926 | 0.240 |
Why?
|
| Female | 64 | 2024 | 397515 | 0.240 |
Why?
|
| Catheterization | 6 | 2004 | 1431 | 0.240 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2016 | 1756 | 0.240 |
Why?
|
| Macrophages | 9 | 2023 | 5801 | 0.240 |
Why?
|
| Structure-Activity Relationship | 3 | 2009 | 3057 | 0.230 |
Why?
|
| Molecular Imaging | 1 | 2011 | 826 | 0.230 |
Why?
|
| Sweetening Agents | 1 | 2007 | 290 | 0.230 |
Why?
|
| Chemokines | 1 | 2009 | 963 | 0.230 |
Why?
|
| Fluorescence Resonance Energy Transfer | 2 | 2004 | 414 | 0.230 |
Why?
|
| Echocardiography, Doppler | 2 | 2020 | 898 | 0.230 |
Why?
|
| Nanostructures | 2 | 2023 | 553 | 0.230 |
Why?
|
| Neoplasms | 6 | 2015 | 22389 | 0.230 |
Why?
|
| Hypoglycemic Agents | 2 | 2014 | 3110 | 0.230 |
Why?
|
| Databases, Factual | 3 | 2017 | 8094 | 0.230 |
Why?
|
| Endosomes | 1 | 2007 | 525 | 0.230 |
Why?
|
| Immunity | 2 | 2007 | 1003 | 0.230 |
Why?
|
| Umbilical Veins | 3 | 2010 | 425 | 0.220 |
Why?
|
| Intracranial Aneurysm | 1 | 2014 | 1293 | 0.220 |
Why?
|
| Proto-Oncogene Proteins c-cbl | 2 | 2015 | 120 | 0.220 |
Why?
|
| Sex Factors | 1 | 2018 | 10633 | 0.220 |
Why?
|
| Vasodilation | 4 | 2017 | 967 | 0.220 |
Why?
|
| Constriction, Pathologic | 6 | 2012 | 1104 | 0.220 |
Why?
|
| Random Allocation | 3 | 2019 | 2394 | 0.220 |
Why?
|
| Liver Transplantation | 1 | 2016 | 2403 | 0.220 |
Why?
|
| Matrix Metalloproteinase 9 | 2 | 2018 | 633 | 0.220 |
Why?
|
| Pericardium | 4 | 2018 | 679 | 0.220 |
Why?
|
| Platelet Aggregation | 1 | 2007 | 769 | 0.220 |
Why?
|
| Elasticity | 4 | 2021 | 657 | 0.220 |
Why?
|
| Muscle, Skeletal | 2 | 2009 | 4978 | 0.220 |
Why?
|
| Epithelium | 1 | 2008 | 1607 | 0.220 |
Why?
|
| Publications | 2 | 2018 | 195 | 0.210 |
Why?
|
| Diabetes Complications | 1 | 2010 | 1320 | 0.210 |
Why?
|
| NF-kappa B | 2 | 2009 | 2492 | 0.210 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2010 | 2893 | 0.210 |
Why?
|
| Epstein-Barr Virus Infections | 2 | 2020 | 617 | 0.200 |
Why?
|
| Thrombolytic Therapy | 2 | 2023 | 2055 | 0.200 |
Why?
|
| Excipients | 2 | 2020 | 98 | 0.200 |
Why?
|
| Polyvinyls | 8 | 1998 | 156 | 0.200 |
Why?
|
| Angiogenesis Inhibitors | 3 | 2001 | 2059 | 0.200 |
Why?
|
| Physician-Patient Relations | 1 | 2015 | 3269 | 0.200 |
Why?
|
| Nitric Oxide Synthase Type III | 5 | 2014 | 706 | 0.200 |
Why?
|
| X-Ray Microtomography | 3 | 2021 | 457 | 0.200 |
Why?
|
| Plethysmography | 1 | 2022 | 173 | 0.200 |
Why?
|
| Capillary Permeability | 3 | 2016 | 773 | 0.200 |
Why?
|
| Myocardium | 7 | 2015 | 4790 | 0.200 |
Why?
|
| Transplantation, Heterologous | 6 | 2007 | 2395 | 0.200 |
Why?
|
| Aortic Valve | 3 | 2023 | 1969 | 0.190 |
Why?
|
| Cell Survival | 4 | 2015 | 5793 | 0.190 |
Why?
|
| Immunohistochemistry | 6 | 2019 | 11116 | 0.190 |
Why?
|
| COUP Transcription Factor II | 1 | 2021 | 19 | 0.190 |
Why?
|
| Carotid Artery, Internal | 1 | 2004 | 445 | 0.190 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2002 | 368 | 0.190 |
Why?
|
| Fatal Outcome | 2 | 2020 | 1836 | 0.180 |
Why?
|
| Registries | 1 | 2017 | 8384 | 0.180 |
Why?
|
| Orphan Nuclear Receptors | 1 | 2021 | 63 | 0.180 |
Why?
|
| Carotid Artery Diseases | 2 | 2021 | 878 | 0.180 |
Why?
|
| Biopsy, Needle | 2 | 2019 | 1626 | 0.180 |
Why?
|
| Gold | 2 | 2004 | 488 | 0.180 |
Why?
|
| Respiratory Rate | 1 | 2022 | 180 | 0.180 |
Why?
|
| Ketones | 1 | 2022 | 183 | 0.180 |
Why?
|
| Gene Expression | 5 | 2016 | 7603 | 0.180 |
Why?
|
| Blood Proteins | 2 | 2004 | 1191 | 0.180 |
Why?
|
| Platelet Activation | 1 | 2004 | 644 | 0.180 |
Why?
|
| Predictive Value of Tests | 9 | 2021 | 15471 | 0.180 |
Why?
|
| Hepatic Artery | 1 | 2022 | 232 | 0.180 |
Why?
|
| Polyethylene | 1 | 2022 | 187 | 0.180 |
Why?
|
| Laminin | 1 | 2002 | 406 | 0.180 |
Why?
|
| Receptors, Immunologic | 4 | 2016 | 1418 | 0.180 |
Why?
|
| Protein Binding | 7 | 2009 | 9344 | 0.180 |
Why?
|
| Liver Cirrhosis | 2 | 2023 | 1962 | 0.180 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 4 | 2008 | 3813 | 0.170 |
Why?
|
| United States Food and Drug Administration | 3 | 2020 | 1672 | 0.170 |
Why?
|
| Mice, Inbred C57BL | 10 | 2019 | 22379 | 0.170 |
Why?
|
| Nucleic Acid Synthesis Inhibitors | 1 | 2020 | 109 | 0.170 |
Why?
|
| Aorta, Abdominal | 2 | 2009 | 627 | 0.170 |
Why?
|
| Nickel | 1 | 2020 | 126 | 0.170 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 2 | 1997 | 178 | 0.170 |
Why?
|
| Endocytosis | 1 | 2004 | 959 | 0.170 |
Why?
|
| Myocardial Infarction | 7 | 2020 | 11521 | 0.170 |
Why?
|
| Blood Pressure Determination | 2 | 2021 | 646 | 0.170 |
Why?
|
| Heart Valves | 2 | 2020 | 284 | 0.170 |
Why?
|
| Ventricular Function, Right | 1 | 2024 | 628 | 0.170 |
Why?
|
| Speech | 2 | 2021 | 558 | 0.170 |
Why?
|
| Fibrinolytic Agents | 4 | 2023 | 2080 | 0.170 |
Why?
|
| Surface Properties | 5 | 2017 | 1169 | 0.170 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2005 | 977 | 0.170 |
Why?
|
| Culture Media | 2 | 2012 | 898 | 0.170 |
Why?
|
| Chemistry, Pharmaceutical | 2 | 2007 | 275 | 0.170 |
Why?
|
| Alginates | 8 | 2022 | 250 | 0.170 |
Why?
|
| Forelimb | 1 | 2019 | 116 | 0.160 |
Why?
|
| Killer Cells, Natural | 1 | 2009 | 2211 | 0.160 |
Why?
|
| Blotting, Western | 3 | 2015 | 5033 | 0.160 |
Why?
|
| Hypokalemia | 1 | 2020 | 152 | 0.160 |
Why?
|
| Ganglia | 1 | 2019 | 86 | 0.160 |
Why?
|
| Joints | 1 | 2001 | 324 | 0.160 |
Why?
|
| Molecular Weight | 4 | 2010 | 2173 | 0.160 |
Why?
|
| Carrier Proteins | 4 | 2018 | 4939 | 0.160 |
Why?
|
| Intercellular Adhesion Molecule-1 | 2 | 2013 | 1133 | 0.160 |
Why?
|
| Spleen | 4 | 2009 | 2294 | 0.160 |
Why?
|
| Tissue Preservation | 1 | 2019 | 173 | 0.160 |
Why?
|
| Magnetics | 4 | 1993 | 599 | 0.160 |
Why?
|
| beta Catenin | 2 | 2015 | 1047 | 0.160 |
Why?
|
| PC12 Cells | 2 | 2009 | 317 | 0.160 |
Why?
|
| Stainless Steel | 3 | 2004 | 79 | 0.160 |
Why?
|
| Heart Valve Prosthesis Implantation | 2 | 2023 | 1568 | 0.160 |
Why?
|
| Serum Albumin | 1 | 2002 | 677 | 0.160 |
Why?
|
| Disease Progression | 11 | 2021 | 13674 | 0.160 |
Why?
|
| Middle Aged | 31 | 2021 | 223737 | 0.160 |
Why?
|
| Dimethylpolysiloxanes | 1 | 2019 | 143 | 0.160 |
Why?
|
| Blood Chemical Analysis | 1 | 2020 | 436 | 0.160 |
Why?
|
| Polyurethanes | 1 | 2019 | 110 | 0.150 |
Why?
|
| Biotechnology | 2 | 2018 | 283 | 0.150 |
Why?
|
| Endothelial Growth Factors | 3 | 1998 | 674 | 0.150 |
Why?
|
| Replantation | 1 | 2019 | 145 | 0.150 |
Why?
|
| Fibronectins | 1 | 2002 | 724 | 0.150 |
Why?
|
| Adenocarcinoma | 1 | 2016 | 6401 | 0.150 |
Why?
|
| Insulin | 7 | 2010 | 6610 | 0.150 |
Why?
|
| Randomized Controlled Trials as Topic | 6 | 2024 | 10400 | 0.150 |
Why?
|
| Ubiquitination | 2 | 2013 | 1010 | 0.150 |
Why?
|
| Pancreatic Neoplasms | 1 | 2016 | 5443 | 0.150 |
Why?
|
| Cholesterol, Dietary | 1 | 2018 | 224 | 0.150 |
Why?
|
| Cytotoxins | 1 | 1998 | 154 | 0.150 |
Why?
|
| Cardiomyopathies | 2 | 2009 | 2057 | 0.150 |
Why?
|
| Graphite | 1 | 2018 | 79 | 0.150 |
Why?
|
| Lymphokines | 3 | 1998 | 927 | 0.150 |
Why?
|
| Chondrocytes | 1 | 2023 | 800 | 0.150 |
Why?
|
| Ventricular Fibrillation | 1 | 2020 | 537 | 0.150 |
Why?
|
| Phenotype | 5 | 2022 | 16731 | 0.150 |
Why?
|
| Titanium | 1 | 2020 | 495 | 0.150 |
Why?
|
| Fishes | 1 | 2001 | 606 | 0.150 |
Why?
|
| Iohexol | 2 | 2017 | 205 | 0.150 |
Why?
|
| Blood Glucose | 5 | 2018 | 6435 | 0.140 |
Why?
|
| History, 20th Century | 3 | 2018 | 2771 | 0.140 |
Why?
|
| Fibroblasts | 3 | 2022 | 4179 | 0.140 |
Why?
|
| Cycloheximide | 1 | 2017 | 341 | 0.140 |
Why?
|
| Vascular Grafting | 1 | 2019 | 163 | 0.140 |
Why?
|
| Reproducibility of Results | 7 | 2021 | 20245 | 0.140 |
Why?
|
| Cytokines | 5 | 2023 | 7453 | 0.140 |
Why?
|
| TOR Serine-Threonine Kinases | 4 | 2018 | 2063 | 0.140 |
Why?
|
| Blood Viscosity | 2 | 2008 | 125 | 0.140 |
Why?
|
| Reference Values | 3 | 2019 | 4940 | 0.140 |
Why?
|
| Gene Expression Regulation | 8 | 2021 | 11932 | 0.140 |
Why?
|
| Platelet Activating Factor | 1 | 1997 | 143 | 0.140 |
Why?
|
| Cartilage | 1 | 2001 | 811 | 0.140 |
Why?
|
| Renal Dialysis | 3 | 2021 | 1789 | 0.140 |
Why?
|
| Indican | 2 | 2015 | 16 | 0.140 |
Why?
|
| Electrodes | 1 | 2019 | 617 | 0.140 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 2018 | 276 | 0.140 |
Why?
|
| Luminescent Proteins | 1 | 2019 | 839 | 0.140 |
Why?
|
| Nanocomposites | 1 | 2017 | 53 | 0.140 |
Why?
|
| Tachycardia | 3 | 2015 | 599 | 0.140 |
Why?
|
| Fluorescein | 2 | 2011 | 175 | 0.140 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2010 | 4592 | 0.140 |
Why?
|
| Busulfan | 1 | 1997 | 259 | 0.130 |
Why?
|
| Leukocytes | 2 | 2004 | 2034 | 0.130 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2021 | 709 | 0.130 |
Why?
|
| Mice, Transgenic | 5 | 2012 | 9565 | 0.130 |
Why?
|
| Diterpenes | 1 | 1997 | 170 | 0.130 |
Why?
|
| Catecholamines | 3 | 2020 | 389 | 0.130 |
Why?
|
| Lamivudine | 1 | 2018 | 367 | 0.130 |
Why?
|
| Models, Molecular | 2 | 2003 | 5404 | 0.130 |
Why?
|
| Retrospective Studies | 8 | 2024 | 81903 | 0.130 |
Why?
|
| Drug Carriers | 7 | 2000 | 710 | 0.130 |
Why?
|
| Plant Proteins | 1 | 1998 | 376 | 0.130 |
Why?
|
| Research | 2 | 2017 | 1981 | 0.130 |
Why?
|
| Muscles | 1 | 2001 | 1582 | 0.130 |
Why?
|
| Culture Techniques | 3 | 2004 | 530 | 0.130 |
Why?
|
| Microscopy, Atomic Force | 2 | 2022 | 250 | 0.130 |
Why?
|
| History, 17th Century | 1 | 2016 | 108 | 0.130 |
Why?
|
| Neoplasm Transplantation | 2 | 2011 | 2018 | 0.130 |
Why?
|
| Solutions | 4 | 2019 | 410 | 0.130 |
Why?
|
| Zidovudine | 1 | 2018 | 625 | 0.130 |
Why?
|
| Amides | 1 | 1998 | 452 | 0.130 |
Why?
|
| Dendritic Cells | 1 | 2007 | 2748 | 0.130 |
Why?
|
| Wounds and Injuries | 2 | 2008 | 2517 | 0.130 |
Why?
|
| Cell Line | 6 | 2015 | 15604 | 0.130 |
Why?
|
| Aorta, Thoracic | 2 | 2022 | 1112 | 0.130 |
Why?
|
| Spectrum Analysis, Raman | 1 | 2018 | 253 | 0.130 |
Why?
|
| Rheology | 1 | 2017 | 348 | 0.130 |
Why?
|
| Health Care Sector | 1 | 2017 | 197 | 0.130 |
Why?
|
| Hyperglycemia | 2 | 2005 | 1389 | 0.130 |
Why?
|
| Magnesium | 1 | 2019 | 816 | 0.130 |
Why?
|
| Infusions, Intravenous | 6 | 2014 | 2231 | 0.130 |
Why?
|
| Robotics | 1 | 2022 | 826 | 0.130 |
Why?
|
| Arginase | 1 | 2016 | 81 | 0.130 |
Why?
|
| Diabetes Mellitus, Type 1 | 2 | 2010 | 3447 | 0.130 |
Why?
|
| Extremities | 1 | 2001 | 870 | 0.130 |
Why?
|
| Sequence Analysis, RNA | 1 | 2023 | 2041 | 0.120 |
Why?
|
| Aftercare | 1 | 2021 | 921 | 0.120 |
Why?
|
| Aldosterone | 1 | 2020 | 881 | 0.120 |
Why?
|
| Fracture Healing | 2 | 2017 | 448 | 0.120 |
Why?
|
| Causality | 1 | 2001 | 1256 | 0.120 |
Why?
|
| Intestine, Small | 3 | 2012 | 1218 | 0.120 |
Why?
|
| Hypercholesterolemia | 4 | 2021 | 1145 | 0.120 |
Why?
|
| Transaminases | 1 | 2016 | 199 | 0.120 |
Why?
|
| Equipment and Supplies | 1 | 2017 | 274 | 0.120 |
Why?
|
| Interferon-gamma | 4 | 2013 | 3163 | 0.120 |
Why?
|
| Skull | 1 | 2019 | 830 | 0.120 |
Why?
|
| Artifacts | 1 | 2024 | 1942 | 0.120 |
Why?
|
| Matrix Metalloproteinases | 3 | 2013 | 393 | 0.120 |
Why?
|
| Pancreas | 1 | 2022 | 1700 | 0.120 |
Why?
|
| Inflammation Mediators | 2 | 2018 | 1890 | 0.120 |
Why?
|
| External Fixators | 1 | 2015 | 99 | 0.120 |
Why?
|
| Amyloid beta-Peptides | 1 | 2008 | 3913 | 0.120 |
Why?
|
| Reverse Transcriptase Inhibitors | 1 | 2018 | 622 | 0.120 |
Why?
|
| Somatostatin | 1 | 1996 | 458 | 0.120 |
Why?
|
| Triiodobenzoic Acids | 1 | 2014 | 123 | 0.120 |
Why?
|
| Private Sector | 1 | 2017 | 396 | 0.120 |
Why?
|
| Myocardial Ischemia | 6 | 2012 | 2139 | 0.120 |
Why?
|
| Electromagnetic Phenomena | 2 | 1987 | 159 | 0.120 |
Why?
|
| beta-Alanine | 1 | 2015 | 82 | 0.120 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2021 | 709 | 0.120 |
Why?
|
| Herpesvirus 4, Human | 1 | 2020 | 1082 | 0.120 |
Why?
|
| Interleukin-4 | 2 | 2009 | 1157 | 0.120 |
Why?
|
| Aged | 23 | 2023 | 171786 | 0.120 |
Why?
|
| Needles | 1 | 2017 | 461 | 0.120 |
Why?
|
| Clinical Medicine | 1 | 2015 | 145 | 0.110 |
Why?
|
| Financing, Government | 1 | 2017 | 473 | 0.110 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2001 | 1629 | 0.110 |
Why?
|
| Microscopy, Electron, Scanning | 4 | 2004 | 945 | 0.110 |
Why?
|
| Gene Expression Profiling | 2 | 2021 | 9549 | 0.110 |
Why?
|
| Sepharose | 3 | 2009 | 102 | 0.110 |
Why?
|
| Cell-Matrix Junctions | 1 | 2013 | 21 | 0.110 |
Why?
|
| Drug Therapy | 1 | 1997 | 504 | 0.110 |
Why?
|
| Cyclic AMP | 2 | 2015 | 1469 | 0.110 |
Why?
|
| Sensitivity and Specificity | 4 | 2021 | 14752 | 0.110 |
Why?
|
| Catalysis | 2 | 2006 | 768 | 0.110 |
Why?
|
| Genes, myc | 1 | 1995 | 391 | 0.110 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 2 | 2014 | 692 | 0.110 |
Why?
|
| Cell Cycle | 4 | 2008 | 2937 | 0.110 |
Why?
|
| Angiography | 5 | 2019 | 1598 | 0.110 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2019 | 3744 | 0.110 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2021 | 1006 | 0.110 |
Why?
|
| Garlic | 1 | 2013 | 28 | 0.110 |
Why?
|
| Ligands | 3 | 2007 | 3283 | 0.110 |
Why?
|
| Blood Coagulation | 4 | 2007 | 1161 | 0.110 |
Why?
|
| Plasmids | 1 | 2018 | 2269 | 0.110 |
Why?
|
| Interleukin-6 | 2 | 2015 | 3232 | 0.110 |
Why?
|
| Tight Junctions | 1 | 2016 | 324 | 0.110 |
Why?
|
| Collagen Type IV | 1 | 2013 | 125 | 0.110 |
Why?
|
| Bone Substitutes | 1 | 2015 | 233 | 0.110 |
Why?
|
| Femoral Fractures | 1 | 2017 | 376 | 0.110 |
Why?
|
| Acute Disease | 2 | 2021 | 7245 | 0.110 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2002 | 1335 | 0.110 |
Why?
|
| Immunotherapy | 2 | 2023 | 4756 | 0.100 |
Why?
|
| DNA Replication | 1 | 2020 | 1428 | 0.100 |
Why?
|
| Indoleacetic Acids | 1 | 2012 | 45 | 0.100 |
Why?
|
| Hexuronic Acids | 6 | 2013 | 145 | 0.100 |
Why?
|
| Glucuronic Acid | 6 | 2013 | 150 | 0.100 |
Why?
|
| Punctures | 2 | 2010 | 372 | 0.100 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2015 | 221 | 0.100 |
Why?
|
| Viral Proteins | 1 | 2020 | 1802 | 0.100 |
Why?
|
| Escherichia coli | 2 | 2022 | 4213 | 0.100 |
Why?
|
| Epoprostenol | 2 | 2005 | 246 | 0.100 |
Why?
|
| Oxygen | 1 | 2024 | 4272 | 0.100 |
Why?
|
| Mathematics | 2 | 2006 | 704 | 0.100 |
Why?
|
| Procollagen | 1 | 2013 | 189 | 0.100 |
Why?
|
| Osteogenesis | 1 | 2019 | 1295 | 0.100 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2020 | 997 | 0.100 |
Why?
|
| Phantoms, Imaging | 2 | 2017 | 2533 | 0.100 |
Why?
|
| Drug Administration Routes | 2 | 2011 | 151 | 0.100 |
Why?
|
| Plant Preparations | 1 | 2013 | 94 | 0.100 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 1 | 2018 | 558 | 0.100 |
Why?
|
| Hydrocortisone | 1 | 2020 | 1841 | 0.100 |
Why?
|
| Leukocyte Count | 4 | 2003 | 1609 | 0.100 |
Why?
|
| Ventricular Function | 1 | 2014 | 406 | 0.100 |
Why?
|
| Syndecan-4 | 1 | 2012 | 45 | 0.100 |
Why?
|
| Vasa Vasorum | 1 | 1992 | 25 | 0.100 |
Why?
|
| Tunica Media | 1 | 2012 | 111 | 0.100 |
Why?
|
| Adhesives | 1 | 2012 | 67 | 0.100 |
Why?
|
| Aortic Diseases | 1 | 2018 | 741 | 0.100 |
Why?
|
| Metabolic Clearance Rate | 2 | 2004 | 363 | 0.100 |
Why?
|
| Cardiac Tamponade | 1 | 1993 | 175 | 0.100 |
Why?
|
| Biology | 1 | 2014 | 292 | 0.100 |
Why?
|
| Injections, Intravenous | 4 | 2001 | 1379 | 0.100 |
Why?
|
| Aged, 80 and over | 8 | 2021 | 59739 | 0.100 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 1992 | 196 | 0.100 |
Why?
|
| Proteolipids | 1 | 2012 | 112 | 0.100 |
Why?
|
| Tibial Fractures | 1 | 2015 | 276 | 0.100 |
Why?
|
| HLA-DR Antigens | 1 | 2013 | 609 | 0.100 |
Why?
|
| Ischemia | 2 | 2012 | 1900 | 0.100 |
Why?
|
| Elastic Modulus | 1 | 2012 | 211 | 0.100 |
Why?
|
| Guinea Pigs | 2 | 2024 | 1309 | 0.100 |
Why?
|
| Morpholines | 1 | 2015 | 584 | 0.100 |
Why?
|
| Diagnosis, Differential | 3 | 2020 | 13021 | 0.100 |
Why?
|
| Rats, Zucker | 2 | 2008 | 131 | 0.090 |
Why?
|
| Crystallization | 1 | 2012 | 520 | 0.090 |
Why?
|
| Porphyrins | 1 | 2013 | 352 | 0.090 |
Why?
|
| Hemorrhage | 3 | 2018 | 3466 | 0.090 |
Why?
|
| Systole | 1 | 1993 | 937 | 0.090 |
Why?
|
| Collagen Type II | 1 | 2011 | 151 | 0.090 |
Why?
|
| Microscopy, Fluorescence | 4 | 2016 | 2635 | 0.090 |
Why?
|
| Cholesterol | 4 | 2013 | 2913 | 0.090 |
Why?
|
| Vascular Malformations | 1 | 2016 | 469 | 0.090 |
Why?
|
| Risk Factors | 12 | 2023 | 74976 | 0.090 |
Why?
|
| Vasoconstrictor Agents | 1 | 2014 | 657 | 0.090 |
Why?
|
| Organ Culture Techniques | 1 | 2013 | 796 | 0.090 |
Why?
|
| Adult | 17 | 2022 | 223851 | 0.090 |
Why?
|
| Microspheres | 4 | 2004 | 789 | 0.090 |
Why?
|
| Lung | 2 | 2008 | 10099 | 0.090 |
Why?
|
| Drug Resistance | 3 | 2016 | 1599 | 0.090 |
Why?
|
| Gelatinases | 1 | 2010 | 93 | 0.090 |
Why?
|
| Integrins | 2 | 2012 | 843 | 0.090 |
Why?
|
| CHO Cells | 2 | 2008 | 1379 | 0.090 |
Why?
|
| Recurrence | 9 | 2007 | 8513 | 0.090 |
Why?
|
| Up-Regulation | 2 | 2018 | 4148 | 0.090 |
Why?
|
| Thiophenes | 1 | 2015 | 570 | 0.090 |
Why?
|
| Calcium | 4 | 2022 | 5792 | 0.090 |
Why?
|
| Echocardiography, Three-Dimensional | 2 | 2014 | 615 | 0.090 |
Why?
|
| Lymph Nodes | 1 | 2022 | 3473 | 0.090 |
Why?
|
| Poloxamer | 2 | 2024 | 56 | 0.090 |
Why?
|
| Myocytes, Cardiac | 2 | 2009 | 1682 | 0.090 |
Why?
|
| Fracture Fixation, Internal | 1 | 2017 | 982 | 0.090 |
Why?
|
| Carotid Stenosis | 1 | 1997 | 862 | 0.090 |
Why?
|
| Subcutaneous Tissue | 1 | 2010 | 131 | 0.090 |
Why?
|
| Compressive Strength | 1 | 2010 | 159 | 0.080 |
Why?
|
| United States | 7 | 2020 | 73186 | 0.080 |
Why?
|
| Antioxidants | 1 | 1998 | 1673 | 0.080 |
Why?
|
| Adhesiveness | 1 | 2009 | 52 | 0.080 |
Why?
|
| Injections, Subcutaneous | 2 | 2006 | 687 | 0.080 |
Why?
|
| Levodopa | 1 | 2010 | 221 | 0.080 |
Why?
|
| Serum Albumin, Bovine | 5 | 1992 | 320 | 0.080 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2016 | 1434 | 0.080 |
Why?
|
| Collagen Type I | 1 | 2013 | 620 | 0.080 |
Why?
|
| Angiopoietin-2 | 1 | 2011 | 186 | 0.080 |
Why?
|
| src-Family Kinases | 1 | 2012 | 539 | 0.080 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 1997 | 1248 | 0.080 |
Why?
|
| Cricetinae | 2 | 2008 | 2423 | 0.080 |
Why?
|
| Benzimidazoles | 1 | 2015 | 864 | 0.080 |
Why?
|
| Pulmonary Embolism | 1 | 2023 | 2600 | 0.080 |
Why?
|
| Heart Transplantation | 1 | 2003 | 3301 | 0.080 |
Why?
|
| Tensile Strength | 1 | 2010 | 335 | 0.080 |
Why?
|
| RNA, Messenger | 5 | 2009 | 12806 | 0.080 |
Why?
|
| Quality of Life | 3 | 2020 | 13510 | 0.080 |
Why?
|
| Lower Extremity | 1 | 2017 | 1217 | 0.080 |
Why?
|
| Sheep | 3 | 2019 | 1451 | 0.080 |
Why?
|
| Hemostatics | 2 | 2002 | 246 | 0.080 |
Why?
|
| Tissue Adhesions | 1 | 2010 | 223 | 0.080 |
Why?
|
| Iodine Radioisotopes | 3 | 2000 | 1034 | 0.080 |
Why?
|
| Implants, Experimental | 1 | 2009 | 99 | 0.080 |
Why?
|
| Mice, Nude | 1 | 2015 | 3631 | 0.080 |
Why?
|
| Blood-Brain Barrier | 1 | 2016 | 1036 | 0.080 |
Why?
|
| Tumor Microenvironment | 2 | 2013 | 3952 | 0.080 |
Why?
|
| Kruppel-Like Transcription Factors | 2 | 2014 | 507 | 0.080 |
Why?
|
| Interleukin-1beta | 3 | 2010 | 1026 | 0.080 |
Why?
|
| Photosensitizing Agents | 1 | 2013 | 630 | 0.080 |
Why?
|
| Light | 1 | 2015 | 1355 | 0.080 |
Why?
|
| Fatigue | 3 | 2022 | 1557 | 0.080 |
Why?
|
| Diabetic Ketoacidosis | 1 | 1992 | 257 | 0.080 |
Why?
|
| Chemokine CX3CL1 | 1 | 2009 | 62 | 0.080 |
Why?
|
| Uncertainty | 1 | 2014 | 769 | 0.080 |
Why?
|
| Double-Blind Method | 5 | 2020 | 12467 | 0.080 |
Why?
|
| MicroRNAs | 2 | 2015 | 3811 | 0.080 |
Why?
|
| Protein Denaturation | 2 | 2003 | 242 | 0.080 |
Why?
|
| Zebrafish Proteins | 1 | 2015 | 1019 | 0.080 |
Why?
|
| Caspase 3 | 1 | 2011 | 731 | 0.080 |
Why?
|
| Image Processing, Computer-Assisted | 6 | 2023 | 9080 | 0.080 |
Why?
|
| Biopolymers | 3 | 1997 | 183 | 0.080 |
Why?
|
| Mitosis | 1 | 1993 | 1181 | 0.080 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2010 | 269 | 0.080 |
Why?
|
| Patient Discharge | 1 | 2021 | 3491 | 0.080 |
Why?
|
| Lipoproteins, LDL | 3 | 2018 | 643 | 0.080 |
Why?
|
| Rats, Inbred SHR | 1 | 2008 | 186 | 0.080 |
Why?
|
| Spectrum Analysis | 1 | 2010 | 449 | 0.080 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2012 | 835 | 0.080 |
Why?
|
| RNA | 2 | 2015 | 2727 | 0.080 |
Why?
|
| Glycosaminoglycans | 2 | 2002 | 611 | 0.080 |
Why?
|
| Injections, Intralesional | 1 | 2009 | 280 | 0.080 |
Why?
|
| Reoperation | 2 | 2010 | 4342 | 0.080 |
Why?
|
| Drug Compounding | 2 | 2007 | 243 | 0.070 |
Why?
|
| Normal Distribution | 2 | 2021 | 272 | 0.070 |
Why?
|
| Feasibility Studies | 5 | 2021 | 5323 | 0.070 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2017 | 1902 | 0.070 |
Why?
|
| Cell Nucleus | 2 | 2015 | 2885 | 0.070 |
Why?
|
| Glucagon | 1 | 2010 | 535 | 0.070 |
Why?
|
| T-Lymphocytes | 4 | 2013 | 10276 | 0.070 |
Why?
|
| Photomicrography | 1 | 2007 | 72 | 0.070 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2007 | 615 | 0.070 |
Why?
|
| Cytoprotection | 1 | 2008 | 200 | 0.070 |
Why?
|
| Compliance | 2 | 2015 | 100 | 0.070 |
Why?
|
| Antiviral Agents | 1 | 2020 | 3070 | 0.070 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2016 | 3621 | 0.070 |
Why?
|
| Single-Cell Analysis | 1 | 2019 | 2542 | 0.070 |
Why?
|
| Electromagnetic Fields | 2 | 1992 | 289 | 0.070 |
Why?
|
| Autocrine Communication | 1 | 2008 | 168 | 0.070 |
Why?
|
| Injections, Intramuscular | 1 | 2009 | 556 | 0.070 |
Why?
|
| Vascular Endothelial Growth Factor A | 5 | 2013 | 3518 | 0.070 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2008 | 612 | 0.070 |
Why?
|
| Diagnostic Imaging | 1 | 2021 | 3538 | 0.070 |
Why?
|
| Umbilical Cord | 1 | 2008 | 179 | 0.070 |
Why?
|
| Prospective Studies | 10 | 2023 | 54962 | 0.070 |
Why?
|
| Neurotoxins | 1 | 2008 | 240 | 0.070 |
Why?
|
| 3T3 Cells | 3 | 1993 | 1085 | 0.070 |
Why?
|
| Cyclosporine | 1 | 2009 | 777 | 0.070 |
Why?
|
| Drug Evaluation, Preclinical | 3 | 2015 | 1340 | 0.070 |
Why?
|
| Models, Theoretical | 3 | 2014 | 3580 | 0.070 |
Why?
|
| Receptor Cross-Talk | 1 | 2007 | 118 | 0.070 |
Why?
|
| Lymphocyte Culture Test, Mixed | 1 | 2007 | 510 | 0.070 |
Why?
|
| Receptors, Lipoprotein | 2 | 1997 | 88 | 0.070 |
Why?
|
| Cell Line, Tumor | 2 | 2016 | 17173 | 0.070 |
Why?
|
| Oligonucleotides | 2 | 2003 | 563 | 0.070 |
Why?
|
| Point-of-Care Systems | 1 | 2015 | 1240 | 0.070 |
Why?
|
| Valine | 1 | 2008 | 410 | 0.070 |
Why?
|
| Nanoparticles | 1 | 2018 | 1989 | 0.070 |
Why?
|
| STAT3 Transcription Factor | 1 | 2011 | 874 | 0.070 |
Why?
|
| Injections | 1 | 2009 | 841 | 0.070 |
Why?
|
| Physical Exertion | 1 | 1989 | 668 | 0.070 |
Why?
|
| Severity of Illness Index | 4 | 2021 | 15951 | 0.070 |
Why?
|
| Cricetulus | 1 | 2008 | 812 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2020 | 20776 | 0.070 |
Why?
|
| Flow Cytometry | 2 | 2007 | 5906 | 0.070 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2021 | 3782 | 0.070 |
Why?
|
| Endotoxemia | 1 | 2007 | 198 | 0.070 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2012 | 1096 | 0.070 |
Why?
|
| Feedback, Physiological | 1 | 2008 | 481 | 0.070 |
Why?
|
| Mice, Inbred Strains | 1 | 2009 | 1769 | 0.070 |
Why?
|
| Fluorescent Dyes | 3 | 2006 | 1933 | 0.070 |
Why?
|
| Fluoresceins | 1 | 2006 | 235 | 0.070 |
Why?
|
| Antibodies, Heterophile | 1 | 2006 | 128 | 0.070 |
Why?
|
| Prosthesis Implantation | 1 | 2010 | 594 | 0.060 |
Why?
|
| Simvastatin | 1 | 2008 | 346 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2006 | 3810 | 0.060 |
Why?
|
| Dietary Fats | 2 | 2011 | 2002 | 0.060 |
Why?
|
| Medicine | 1 | 2014 | 947 | 0.060 |
Why?
|
| Lipopolysaccharides | 4 | 2007 | 2222 | 0.060 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2010 | 1169 | 0.060 |
Why?
|
| Interleukin-8 | 2 | 2013 | 705 | 0.060 |
Why?
|
| STAT4 Transcription Factor | 1 | 2005 | 94 | 0.060 |
Why?
|
| Immunoconjugates | 1 | 2013 | 976 | 0.060 |
Why?
|
| Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 2005 | 79 | 0.060 |
Why?
|
| Recombinant Proteins | 6 | 2019 | 6512 | 0.060 |
Why?
|
| Mitral Valve | 1 | 2014 | 1475 | 0.060 |
Why?
|
| Dinoprost | 1 | 2005 | 139 | 0.060 |
Why?
|
| Dinoprostone | 1 | 2008 | 597 | 0.060 |
Why?
|
| Protein Conformation | 2 | 2003 | 3956 | 0.060 |
Why?
|
| Contrast Media | 2 | 2017 | 5334 | 0.060 |
Why?
|
| STAT6 Transcription Factor | 1 | 2005 | 196 | 0.060 |
Why?
|
| Membrane Glycoproteins | 1 | 2016 | 3713 | 0.060 |
Why?
|
| Biomedical Engineering | 2 | 2012 | 286 | 0.060 |
Why?
|
| Peptide Fragments | 2 | 2008 | 5151 | 0.060 |
Why?
|
| Actins | 1 | 2012 | 2065 | 0.060 |
Why?
|
| Neoplasm Invasiveness | 1 | 2013 | 3629 | 0.060 |
Why?
|
| Electroencephalography | 1 | 2020 | 6317 | 0.060 |
Why?
|
| Follow-Up Studies | 6 | 2016 | 39394 | 0.060 |
Why?
|
| Polyvinyl Alcohol | 1 | 1985 | 74 | 0.060 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2008 | 693 | 0.060 |
Why?
|
| Biodegradation, Environmental | 2 | 2000 | 220 | 0.060 |
Why?
|
| Immunologic Factors | 2 | 2018 | 1597 | 0.060 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2020 | 3683 | 0.060 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2009 | 1439 | 0.060 |
Why?
|
| Oxidation-Reduction | 1 | 2010 | 2226 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2011 | 2460 | 0.060 |
Why?
|
| Area Under Curve | 1 | 2008 | 1645 | 0.060 |
Why?
|
| Binding, Competitive | 1 | 2005 | 1142 | 0.060 |
Why?
|
| Water | 1 | 2010 | 1421 | 0.060 |
Why?
|
| Analysis of Variance | 3 | 2017 | 6236 | 0.060 |
Why?
|
| Obesity | 3 | 2015 | 13091 | 0.060 |
Why?
|
| Research Design | 3 | 2013 | 6214 | 0.060 |
Why?
|
| Antihypertensive Agents | 2 | 2016 | 2027 | 0.060 |
Why?
|
| Phosphorus Radioisotopes | 1 | 2003 | 100 | 0.060 |
Why?
|
| Diet, Atherogenic | 1 | 2003 | 92 | 0.060 |
Why?
|
| Conservation of Energy Resources | 1 | 2003 | 20 | 0.060 |
Why?
|
| Biochemical Phenomena | 1 | 2004 | 59 | 0.060 |
Why?
|
| Cardiomyoplasty | 1 | 2003 | 5 | 0.060 |
Why?
|
| Nerve Degeneration | 1 | 2008 | 750 | 0.060 |
Why?
|
| Polyethyleneimine | 1 | 2024 | 68 | 0.060 |
Why?
|
| Hospitalization | 2 | 2021 | 10847 | 0.060 |
Why?
|
| Drug Stability | 1 | 2004 | 292 | 0.050 |
Why?
|
| Acute Coronary Syndrome | 1 | 2016 | 2194 | 0.050 |
Why?
|
| Filtration | 1 | 2004 | 228 | 0.050 |
Why?
|
| Micelles | 1 | 2024 | 191 | 0.050 |
Why?
|
| Alloys | 2 | 2019 | 111 | 0.050 |
Why?
|
| Zebrafish | 1 | 2015 | 3037 | 0.050 |
Why?
|
| Inulin | 2 | 1997 | 67 | 0.050 |
Why?
|
| Ear Cartilage | 1 | 2023 | 62 | 0.050 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2006 | 4413 | 0.050 |
Why?
|
| Neutral Red | 1 | 2022 | 9 | 0.050 |
Why?
|
| Young Adult | 4 | 2022 | 60131 | 0.050 |
Why?
|
| Cells | 1 | 2004 | 166 | 0.050 |
Why?
|
| Photochemistry | 1 | 2003 | 238 | 0.050 |
Why?
|
| Peptide Biosynthesis | 1 | 2002 | 52 | 0.050 |
Why?
|
| Transfection | 1 | 2011 | 5763 | 0.050 |
Why?
|
| Foam Cells | 2 | 2018 | 68 | 0.050 |
Why?
|
| Rose Bengal | 1 | 2003 | 115 | 0.050 |
Why?
|
| Secondary Prevention | 2 | 2000 | 1476 | 0.050 |
Why?
|
| Substrate Specificity | 1 | 2006 | 1751 | 0.050 |
Why?
|
| Intra-Aortic Balloon Pumping | 1 | 2024 | 223 | 0.050 |
Why?
|
| Heart Valve Diseases | 2 | 2003 | 1030 | 0.050 |
Why?
|
| Capillaries | 2 | 2014 | 756 | 0.050 |
Why?
|
| Receptors, Fibronectin | 1 | 2002 | 37 | 0.050 |
Why?
|
| Ventricular Remodeling | 1 | 2010 | 1282 | 0.050 |
Why?
|
| Lipoproteins, HDL | 2 | 1997 | 682 | 0.050 |
Why?
|
| Tetrazoles | 1 | 2008 | 923 | 0.050 |
Why?
|
| Fibrin | 1 | 2005 | 514 | 0.050 |
Why?
|
| Nitric Oxide Synthase | 1 | 2005 | 911 | 0.050 |
Why?
|
| Antibodies | 2 | 2002 | 2422 | 0.050 |
Why?
|
| Fibrin Tissue Adhesive | 1 | 2022 | 87 | 0.050 |
Why?
|
| RNA Interference | 1 | 2011 | 2835 | 0.050 |
Why?
|
| Amines | 2 | 2015 | 280 | 0.050 |
Why?
|
| Forecasting | 1 | 2011 | 2945 | 0.050 |
Why?
|
| Ethers | 1 | 2022 | 73 | 0.050 |
Why?
|
| History, Medieval | 1 | 2001 | 62 | 0.050 |
Why?
|
| Benzophenones | 1 | 2022 | 57 | 0.050 |
Why?
|
| Trachea | 1 | 2008 | 1095 | 0.050 |
Why?
|
| Adsorption | 1 | 2002 | 198 | 0.050 |
Why?
|
| Immunization | 1 | 2006 | 1220 | 0.050 |
Why?
|
| Models, Statistical | 3 | 2015 | 5110 | 0.050 |
Why?
|
| History, 16th Century | 1 | 2001 | 70 | 0.050 |
Why?
|
| Respiratory Mucosa | 1 | 2005 | 439 | 0.050 |
Why?
|
| Capsules | 2 | 1993 | 193 | 0.050 |
Why?
|
| Receptor, EphB2 | 1 | 2001 | 31 | 0.050 |
Why?
|
| Autopsy | 2 | 2022 | 1013 | 0.050 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2005 | 682 | 0.050 |
Why?
|
| Liver Circulation | 1 | 2022 | 159 | 0.050 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2004 | 489 | 0.050 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2007 | 4528 | 0.050 |
Why?
|
| Tissue Transplantation | 1 | 2002 | 128 | 0.050 |
Why?
|
| Protein Kinases | 2 | 2005 | 1611 | 0.050 |
Why?
|
| Binding Sites | 2 | 2003 | 6023 | 0.050 |
Why?
|
| Peptides | 3 | 2002 | 4353 | 0.050 |
Why?
|
| Gene Transfer Techniques | 2 | 2018 | 1209 | 0.050 |
Why?
|
| Intestines | 1 | 2010 | 1911 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factors | 3 | 1998 | 751 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2003 | 18068 | 0.050 |
Why?
|
| History, Ancient | 1 | 2001 | 213 | 0.050 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2011 | 2884 | 0.050 |
Why?
|
| Molecular Targeted Therapy | 1 | 2013 | 2830 | 0.050 |
Why?
|
| Hyperhomocysteinemia | 1 | 2001 | 118 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 1 | 2009 | 6131 | 0.050 |
Why?
|
| Protein Transport | 1 | 2007 | 1956 | 0.050 |
Why?
|
| Mycophenolic Acid | 1 | 2003 | 348 | 0.050 |
Why?
|
| Calibration | 2 | 2004 | 822 | 0.050 |
Why?
|
| Thermodynamics | 1 | 2002 | 591 | 0.050 |
Why?
|
| Prognosis | 1 | 2021 | 30046 | 0.050 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2016 | 5342 | 0.050 |
Why?
|
| Antisense Elements (Genetics) | 1 | 2000 | 37 | 0.040 |
Why?
|
| Regeneration | 3 | 2019 | 1524 | 0.040 |
Why?
|
| Microscopy, Confocal | 1 | 2006 | 1973 | 0.040 |
Why?
|
| Platelet Count | 1 | 2003 | 787 | 0.040 |
Why?
|
| Elastin | 1 | 2002 | 299 | 0.040 |
Why?
|
| Saphenous Vein | 2 | 2019 | 519 | 0.040 |
Why?
|
| Apolipoproteins E | 1 | 2006 | 1461 | 0.040 |
Why?
|
| Chromatography, Ion Exchange | 1 | 2000 | 293 | 0.040 |
Why?
|
| Interleukins | 1 | 2005 | 796 | 0.040 |
Why?
|
| Surface Tension | 1 | 2000 | 43 | 0.040 |
Why?
|
| Equipment Failure Analysis | 1 | 2002 | 848 | 0.040 |
Why?
|
| Coronary Stenosis | 1 | 2006 | 802 | 0.040 |
Why?
|
| Weightlessness | 1 | 1981 | 103 | 0.040 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2003 | 660 | 0.040 |
Why?
|
| Cryoultramicrotomy | 1 | 1999 | 16 | 0.040 |
Why?
|
| Swimming | 1 | 2001 | 209 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2023 | 36854 | 0.040 |
Why?
|
| Liposomes | 1 | 2003 | 793 | 0.040 |
Why?
|
| Dextran Sulfate | 1 | 2000 | 258 | 0.040 |
Why?
|
| Early Diagnosis | 2 | 2016 | 1194 | 0.040 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 1999 | 199 | 0.040 |
Why?
|
| Immunoglobulin G | 2 | 2009 | 4568 | 0.040 |
Why?
|
| Cell Count | 1 | 2003 | 1833 | 0.040 |
Why?
|
| Protein Folding | 1 | 2003 | 871 | 0.040 |
Why?
|
| Therapeutic Equivalency | 1 | 1999 | 134 | 0.040 |
Why?
|
| Myofibroblasts | 1 | 2021 | 230 | 0.040 |
Why?
|
| Phenylephrine | 1 | 2020 | 293 | 0.040 |
Why?
|
| Polyethylenes | 1 | 2022 | 293 | 0.040 |
Why?
|
| Air | 1 | 2000 | 187 | 0.040 |
Why?
|
| Cell Membrane | 1 | 2009 | 3659 | 0.040 |
Why?
|
| Transplantation Immunology | 1 | 2001 | 537 | 0.040 |
Why?
|
| Convection | 1 | 1998 | 30 | 0.040 |
Why?
|
| Macrophage-1 Antigen | 1 | 2000 | 286 | 0.040 |
Why?
|
| Inflation, Economic | 1 | 1999 | 30 | 0.040 |
Why?
|
| Thorax | 1 | 2022 | 557 | 0.040 |
Why?
|
| Ribosome Inactivating Proteins, Type 1 | 1 | 1998 | 28 | 0.040 |
Why?
|
| Lasers | 1 | 2003 | 952 | 0.040 |
Why?
|
| Comorbidity | 1 | 2014 | 10592 | 0.040 |
Why?
|
| Enteritis | 1 | 2000 | 164 | 0.040 |
Why?
|
| Anastomosis, Surgical | 1 | 2022 | 994 | 0.040 |
Why?
|
| Syndrome | 1 | 2005 | 3274 | 0.040 |
Why?
|
| Respiratory System | 1 | 2022 | 565 | 0.040 |
Why?
|
| Fibrosis | 2 | 2021 | 2080 | 0.040 |
Why?
|
| Vestibule, Labyrinth | 1 | 1981 | 235 | 0.040 |
Why?
|
| Multivariate Analysis | 1 | 2012 | 12095 | 0.040 |
Why?
|
| Anisotropy | 1 | 2002 | 1295 | 0.040 |
Why?
|
| Radiography | 1 | 2009 | 6991 | 0.040 |
Why?
|
| Locomotion | 1 | 2001 | 388 | 0.040 |
Why?
|
| Interleukin-1 | 1 | 2002 | 1251 | 0.040 |
Why?
|
| Mice, Knockout | 2 | 2021 | 14484 | 0.040 |
Why?
|
| Probucol | 1 | 1998 | 25 | 0.040 |
Why?
|
| Fibroblast Growth Factor 1 | 1 | 1998 | 53 | 0.040 |
Why?
|
| Thrombectomy | 1 | 2023 | 675 | 0.040 |
Why?
|
| Glutaral | 1 | 2018 | 78 | 0.040 |
Why?
|
| Extracorporeal Circulation | 1 | 1998 | 181 | 0.040 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2006 | 1813 | 0.040 |
Why?
|
| Radiometry | 1 | 2003 | 817 | 0.040 |
Why?
|
| RNA-Binding Proteins | 2 | 1997 | 1891 | 0.040 |
Why?
|
| Heparin Antagonists | 1 | 1997 | 34 | 0.040 |
Why?
|
| Prodrugs | 1 | 2020 | 275 | 0.040 |
Why?
|
| Tricuspid Valve | 1 | 2021 | 419 | 0.040 |
Why?
|
| Europe | 2 | 2016 | 3441 | 0.040 |
Why?
|
| Ginkgolides | 1 | 1997 | 7 | 0.040 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2019 | 344 | 0.040 |
Why?
|
| Cohort Studies | 3 | 2017 | 41808 | 0.040 |
Why?
|
| Capital Financing | 1 | 2017 | 58 | 0.040 |
Why?
|
| Particle Size | 2 | 2017 | 1652 | 0.040 |
Why?
|
| Eye Movements | 1 | 1981 | 514 | 0.040 |
Why?
|
| Transplants | 1 | 1999 | 209 | 0.040 |
Why?
|
| Models, Econometric | 1 | 2017 | 215 | 0.040 |
Why?
|
| Intraoperative Complications | 1 | 2004 | 1176 | 0.030 |
Why?
|
| Mitogens | 1 | 1997 | 229 | 0.030 |
Why?
|
| Prevalence | 1 | 2014 | 15879 | 0.030 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2020 | 481 | 0.030 |
Why?
|
| Glycolysis | 1 | 2021 | 838 | 0.030 |
Why?
|
| Tritium | 1 | 1997 | 707 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 2 | 2018 | 6232 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2021 | 12253 | 0.030 |
Why?
|
| Intestinal Mucosa | 2 | 2005 | 3044 | 0.030 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 1997 | 283 | 0.030 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2000 | 647 | 0.030 |
Why?
|
| Bile | 1 | 1997 | 299 | 0.030 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 1997 | 183 | 0.030 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 1 | 2018 | 252 | 0.030 |
Why?
|
| Chromium Alloys | 1 | 2015 | 71 | 0.030 |
Why?
|
| Gels | 1 | 1997 | 423 | 0.030 |
Why?
|
| Atrial Fibrillation | 1 | 2015 | 5176 | 0.030 |
Why?
|
| Carbon Radioisotopes | 1 | 1997 | 567 | 0.030 |
Why?
|
| Incidence | 1 | 2014 | 21547 | 0.030 |
Why?
|
| Receptors, Peptide | 1 | 1997 | 280 | 0.030 |
Why?
|
| Respiratory Insufficiency | 1 | 2024 | 1241 | 0.030 |
Why?
|
| Pregnancy Complications | 1 | 2009 | 2974 | 0.030 |
Why?
|
| Germany | 1 | 2018 | 883 | 0.030 |
Why?
|
| Trans-Activators | 1 | 2005 | 2858 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 1 | 2002 | 3775 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2002 | 1495 | 0.030 |
Why?
|
| Prenatal Care | 1 | 2023 | 1162 | 0.030 |
Why?
|
| Hematocrit | 1 | 1996 | 623 | 0.030 |
Why?
|
| Neutrophils | 2 | 2015 | 3785 | 0.030 |
Why?
|
| von Willebrand Factor | 1 | 2019 | 680 | 0.030 |
Why?
|
| Bone Marrow | 1 | 2005 | 2936 | 0.030 |
Why?
|
| Biophysical Phenomena | 1 | 1996 | 320 | 0.030 |
Why?
|
| Fluorouracil | 1 | 2000 | 1655 | 0.030 |
Why?
|
| Software | 2 | 2015 | 4479 | 0.030 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 1997 | 368 | 0.030 |
Why?
|
| Risk Assessment | 3 | 2012 | 24333 | 0.030 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 1996 | 619 | 0.030 |
Why?
|
| Mice, Obese | 1 | 2015 | 418 | 0.030 |
Why?
|
| Lactones | 1 | 1997 | 316 | 0.030 |
Why?
|
| Stress, Psychological | 2 | 1990 | 4530 | 0.030 |
Why?
|
| Biophysics | 1 | 1996 | 379 | 0.030 |
Why?
|
| Oligonucleotide Probes | 1 | 1995 | 417 | 0.030 |
Why?
|
| Electroporation | 1 | 1995 | 238 | 0.030 |
Why?
|
| Muscle Relaxation | 1 | 1994 | 138 | 0.030 |
Why?
|
| Genetic Techniques | 1 | 1997 | 428 | 0.030 |
Why?
|
| Platelet Transfusion | 1 | 1997 | 301 | 0.030 |
Why?
|
| Angioplasty, Balloon, Laser-Assisted | 1 | 1994 | 20 | 0.030 |
Why?
|
| Matched-Pair Analysis | 1 | 2015 | 286 | 0.030 |
Why?
|
| Hot Temperature | 1 | 2001 | 1441 | 0.030 |
Why?
|
| Adrenal Glands | 1 | 1996 | 557 | 0.030 |
Why?
|
| Osteoblasts | 1 | 2019 | 1153 | 0.030 |
Why?
|
| Energy Metabolism | 1 | 2005 | 2905 | 0.030 |
Why?
|
| Cell Differentiation | 2 | 2012 | 11684 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2001 | 4040 | 0.030 |
Why?
|
| Computer-Aided Design | 1 | 2015 | 296 | 0.030 |
Why?
|
| Poisson Distribution | 1 | 2015 | 508 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1997 | 1536 | 0.030 |
Why?
|
| Radioisotope Dilution Technique | 1 | 1993 | 71 | 0.030 |
Why?
|
| Phagocytosis | 1 | 2019 | 1530 | 0.030 |
Why?
|
| Therapy, Computer-Assisted | 1 | 2015 | 265 | 0.030 |
Why?
|
| Protein Stability | 1 | 2015 | 580 | 0.030 |
Why?
|
| Proteins | 1 | 2008 | 6011 | 0.030 |
Why?
|
| DNA, Viral | 1 | 2020 | 2205 | 0.030 |
Why?
|
| Infusion Pumps | 1 | 1994 | 163 | 0.030 |
Why?
|
| Heparin Lyase | 1 | 1992 | 37 | 0.030 |
Why?
|
| Sulfur Radioisotopes | 1 | 1992 | 113 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 13698 | 0.030 |
Why?
|
| Heart Rate | 2 | 2015 | 4217 | 0.030 |
Why?
|
| Lipids | 2 | 2018 | 3345 | 0.030 |
Why?
|
| Polysaccharide-Lyases | 1 | 1992 | 48 | 0.030 |
Why?
|
| DNA-Binding Proteins | 2 | 2005 | 9618 | 0.030 |
Why?
|
| Creatinine | 2 | 2014 | 1917 | 0.030 |
Why?
|
| STAT Transcription Factors | 1 | 2013 | 189 | 0.030 |
Why?
|
| Dopamine | 1 | 2020 | 1596 | 0.030 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2013 | 178 | 0.030 |
Why?
|
| Australia | 1 | 2016 | 1265 | 0.030 |
Why?
|
| alpha-Tocopherol | 1 | 2013 | 127 | 0.030 |
Why?
|
| Brain | 2 | 2018 | 27453 | 0.030 |
Why?
|
| Plants, Medicinal | 1 | 2013 | 167 | 0.030 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2006 | 4651 | 0.030 |
Why?
|
| Image Enhancement | 1 | 2023 | 2898 | 0.030 |
Why?
|
| Rupture, Spontaneous | 1 | 2013 | 365 | 0.030 |
Why?
|
| Molecular Sequence Data | 4 | 2007 | 17629 | 0.030 |
Why?
|
| Janus Kinases | 1 | 2013 | 253 | 0.020 |
Why?
|
| Echocardiography, Stress | 1 | 2013 | 139 | 0.020 |
Why?
|
| Virus Replication | 1 | 2020 | 2458 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2021 | 1752 | 0.020 |
Why?
|
| Vagina | 1 | 1998 | 849 | 0.020 |
Why?
|
| History, 21st Century | 1 | 2018 | 1575 | 0.020 |
Why?
|
| Surgical Mesh | 1 | 2015 | 316 | 0.020 |
Why?
|
| Japan | 1 | 2016 | 1418 | 0.020 |
Why?
|
| Metals | 1 | 2016 | 713 | 0.020 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2013 | 432 | 0.020 |
Why?
|
| Graft Survival | 1 | 2002 | 3888 | 0.020 |
Why?
|
| Proto-Oncogenes | 1 | 1992 | 322 | 0.020 |
Why?
|
| Models, Anatomic | 1 | 2015 | 683 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2018 | 2089 | 0.020 |
Why?
|
| beta Carotene | 1 | 2013 | 523 | 0.020 |
Why?
|
| Administration, Topical | 1 | 1993 | 704 | 0.020 |
Why?
|
| Insulin Resistance | 1 | 2005 | 3982 | 0.020 |
Why?
|
| Cathepsin K | 1 | 2011 | 65 | 0.020 |
Why?
|
| Phytotherapy | 1 | 2013 | 298 | 0.020 |
Why?
|
| Anticholesteremic Agents | 1 | 1998 | 972 | 0.020 |
Why?
|
| Ultrasonography | 2 | 2016 | 6002 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2015 | 1742 | 0.020 |
Why?
|
| Enzyme Induction | 1 | 2011 | 455 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2010 | 12174 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 2020 | 2714 | 0.020 |
Why?
|
| Staining and Labeling | 1 | 2014 | 1081 | 0.020 |
Why?
|
| Metanephrine | 1 | 2009 | 25 | 0.020 |
Why?
|
| Methionine | 1 | 1992 | 573 | 0.020 |
Why?
|
| Oxidative Stress | 2 | 2014 | 3139 | 0.020 |
Why?
|
| Membrane Proteins | 2 | 1997 | 7885 | 0.020 |
Why?
|
| Cathepsins | 1 | 2011 | 242 | 0.020 |
Why?
|
| Protein Multimerization | 1 | 2015 | 968 | 0.020 |
Why?
|
| Risk | 2 | 2015 | 9621 | 0.020 |
Why?
|
| Ascorbic Acid | 1 | 2013 | 658 | 0.020 |
Why?
|
| Hindlimb | 1 | 2012 | 516 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2023 | 8748 | 0.020 |
Why?
|
| Cadaver | 1 | 2014 | 1366 | 0.020 |
Why?
|
| Thrombocytopenia | 1 | 1997 | 1181 | 0.020 |
Why?
|
| Patient Selection | 2 | 2018 | 4265 | 0.020 |
Why?
|
| Skin Transplantation | 1 | 2014 | 1097 | 0.020 |
Why?
|
| Base Sequence | 3 | 1995 | 12430 | 0.020 |
Why?
|
| Temperature | 2 | 1987 | 2235 | 0.020 |
Why?
|
| Oncogenes | 1 | 1995 | 1236 | 0.020 |
Why?
|
| Hospital Mortality | 1 | 2023 | 5369 | 0.020 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2019 | 1672 | 0.020 |
Why?
|
| Gastrointestinal Tract | 1 | 2015 | 840 | 0.020 |
Why?
|
| Drug Utilization | 1 | 2015 | 1191 | 0.020 |
Why?
|
| Mortality | 1 | 2020 | 2914 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2016 | 2942 | 0.020 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2003 | 3253 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2014 | 1505 | 0.020 |
Why?
|
| Fetal Death | 1 | 2009 | 434 | 0.020 |
Why?
|
| Propensity Score | 1 | 2015 | 1968 | 0.020 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2013 | 1141 | 0.020 |
Why?
|
| Exercise | 2 | 2023 | 5954 | 0.020 |
Why?
|
| Fasting | 1 | 1994 | 1610 | 0.020 |
Why?
|
| Drainage | 1 | 1993 | 1184 | 0.020 |
Why?
|
| Canada | 1 | 2013 | 2130 | 0.020 |
Why?
|
| Proteomics | 1 | 2021 | 3914 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2005 | 22296 | 0.020 |
Why?
|
| Scavenger Receptors, Class B | 2 | 1997 | 85 | 0.020 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2009 | 586 | 0.020 |
Why?
|
| Clinical Protocols | 1 | 2013 | 1445 | 0.020 |
Why?
|
| Arrhythmias, Cardiac | 1 | 1997 | 2258 | 0.020 |
Why?
|
| Pulmonary Edema | 1 | 2009 | 409 | 0.020 |
Why?
|
| Myocardial Perfusion Imaging | 1 | 2013 | 672 | 0.020 |
Why?
|
| Receptors, Scavenger | 2 | 1997 | 123 | 0.020 |
Why?
|
| Colon | 1 | 2015 | 1803 | 0.020 |
Why?
|
| Alzheimer Disease | 1 | 2008 | 8760 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 1996 | 2488 | 0.020 |
Why?
|
| Thrombomodulin | 1 | 2007 | 107 | 0.020 |
Why?
|
| Rats, Inbred Strains | 2 | 1986 | 2087 | 0.020 |
Why?
|
| Warfarin | 1 | 2015 | 1493 | 0.020 |
Why?
|
| Colitis | 1 | 2015 | 1242 | 0.020 |
Why?
|
| Lung Neoplasms | 1 | 2011 | 13594 | 0.020 |
Why?
|
| Pregnancy | 2 | 2023 | 30265 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 1994 | 4862 | 0.020 |
Why?
|
| Mechanoreceptors | 1 | 2007 | 194 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2015 | 2592 | 0.020 |
Why?
|
| Immune Tolerance | 1 | 2014 | 2323 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2007 | 515 | 0.020 |
Why?
|
| Phthalic Anhydrides | 1 | 1985 | 3 | 0.020 |
Why?
|
| Streptozocin | 1 | 2005 | 190 | 0.020 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 1989 | 775 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 2005 | 185 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 2 | 2000 | 9264 | 0.020 |
Why?
|
| Stem Cells | 1 | 2018 | 3539 | 0.010 |
Why?
|
| Chemistry | 1 | 1985 | 327 | 0.010 |
Why?
|
| Chemical Phenomena | 1 | 1985 | 486 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2005 | 317 | 0.010 |
Why?
|
| Methods | 1 | 1985 | 1066 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2005 | 379 | 0.010 |
Why?
|
| Skin | 2 | 2014 | 4506 | 0.010 |
Why?
|
| Child | 3 | 2023 | 80960 | 0.010 |
Why?
|
| HEK293 Cells | 1 | 2013 | 4290 | 0.010 |
Why?
|
| Hemoglobins | 1 | 2009 | 1531 | 0.010 |
Why?
|
| Transgenes | 1 | 2007 | 1016 | 0.010 |
Why?
|
| Cyclin D1 | 1 | 2005 | 453 | 0.010 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2017 | 2297 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2022 | 7478 | 0.010 |
Why?
|
| Suction | 1 | 2004 | 268 | 0.010 |
Why?
|
| Colonic Neoplasms | 1 | 2015 | 2543 | 0.010 |
Why?
|
| Drug Synergism | 1 | 2007 | 1762 | 0.010 |
Why?
|
| Postpartum Period | 1 | 2009 | 1198 | 0.010 |
Why?
|
| Diagnostic Errors | 1 | 2009 | 1281 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 2004 | 1629 | 0.010 |
Why?
|
| Acute Kidney Injury | 1 | 2014 | 1936 | 0.010 |
Why?
|
| Consensus Development Conferences as Topic | 1 | 2002 | 169 | 0.010 |
Why?
|
| Dyspnea | 1 | 2009 | 1352 | 0.010 |
Why?
|
| Headache | 1 | 2009 | 1264 | 0.010 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2004 | 2763 | 0.010 |
Why?
|
| Tissue Fixation | 1 | 2002 | 245 | 0.010 |
Why?
|
| Kinesthesis | 1 | 1981 | 22 | 0.010 |
Why?
|
| Adolescent | 2 | 2022 | 89244 | 0.010 |
Why?
|
| Single-Blind Method | 1 | 2004 | 1586 | 0.010 |
Why?
|
| DNA | 1 | 2014 | 7214 | 0.010 |
Why?
|
| Glucagon-Like Peptide 2 | 1 | 2000 | 45 | 0.010 |
Why?
|
| Artificial Intelligence | 1 | 2015 | 2666 | 0.010 |
Why?
|
| Species Specificity | 1 | 2004 | 2417 | 0.010 |
Why?
|
| Pre-Eclampsia | 1 | 2009 | 1255 | 0.010 |
Why?
|
| Acceleration | 1 | 1981 | 190 | 0.010 |
Why?
|
| Bromodeoxyuridine | 1 | 2000 | 310 | 0.010 |
Why?
|
| Specimen Handling | 1 | 2004 | 708 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 1994 | 5804 | 0.010 |
Why?
|
| Orientation | 1 | 1981 | 320 | 0.010 |
Why?
|
| Delivery of Health Care | 1 | 2017 | 5375 | 0.010 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2009 | 2145 | 0.010 |
Why?
|
| Glucagon-Like Peptides | 1 | 2000 | 157 | 0.010 |
Why?
|
| Consensus | 1 | 2008 | 3214 | 0.010 |
Why?
|
| Nitric Oxide | 1 | 2007 | 2149 | 0.010 |
Why?
|
| Coloring Agents | 1 | 2000 | 564 | 0.010 |
Why?
|
| Jejunum | 1 | 2000 | 475 | 0.010 |
Why?
|
| Neutrophil Infiltration | 1 | 2000 | 395 | 0.010 |
Why?
|
| Space Flight | 1 | 1981 | 219 | 0.010 |
Why?
|
| Guidelines as Topic | 1 | 2004 | 1399 | 0.010 |
Why?
|
| Kinins | 1 | 1997 | 14 | 0.010 |
Why?
|
| Endothelins | 1 | 1997 | 127 | 0.010 |
Why?
|
| Glucose Oxidase | 1 | 1996 | 18 | 0.010 |
Why?
|
| Collateral Circulation | 1 | 1998 | 291 | 0.010 |
Why?
|
| Chronic Disease | 3 | 1996 | 9384 | 0.010 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2005 | 1560 | 0.010 |
Why?
|
| Iontophoresis | 1 | 1995 | 75 | 0.010 |
Why?
|
| Placebos | 1 | 1999 | 1667 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2007 | 13427 | 0.010 |
Why?
|
| Prostaglandin Endoperoxides, Synthetic | 1 | 1994 | 58 | 0.010 |
Why?
|
| Ketanserin | 1 | 1994 | 24 | 0.010 |
Why?
|
| 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid | 1 | 1994 | 64 | 0.010 |
Why?
|
| Nitroarginine | 1 | 1994 | 66 | 0.010 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 1997 | 617 | 0.010 |
Why?
|
| Calcimycin | 1 | 1994 | 214 | 0.010 |
Why?
|
| Thromboxane A2 | 1 | 1994 | 87 | 0.010 |
Why?
|
| Morbidity | 1 | 2000 | 1757 | 0.010 |
Why?
|
| Nitroprusside | 1 | 1994 | 272 | 0.010 |
Why?
|
| Potassium Chloride | 1 | 1994 | 229 | 0.010 |
Why?
|
| Indomethacin | 1 | 1994 | 323 | 0.010 |
Why?
|
| Adenosine Diphosphate | 1 | 1994 | 422 | 0.010 |
Why?
|
| Safety | 1 | 1998 | 1161 | 0.010 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 1994 | 287 | 0.010 |
Why?
|
| Administration, Cutaneous | 1 | 1995 | 716 | 0.010 |
Why?
|
| Adenoviridae | 1 | 1997 | 1095 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2015 | 42683 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2004 | 8559 | 0.010 |
Why?
|
| Stroke | 1 | 2015 | 9756 | 0.010 |
Why?
|
| Acetylcholine | 1 | 1994 | 629 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-myb | 1 | 1992 | 82 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2000 | 2674 | 0.010 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 1996 | 881 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2008 | 7460 | 0.010 |
Why?
|
| Arginine | 1 | 1994 | 932 | 0.010 |
Why?
|
| Procainamide | 1 | 1989 | 56 | 0.010 |
Why?
|
| Serotonin | 1 | 1994 | 1043 | 0.010 |
Why?
|
| Injections, Intra-Arterial | 1 | 1989 | 181 | 0.010 |
Why?
|
| Body Weight | 1 | 2000 | 4628 | 0.010 |
Why?
|
| Dexamethasone | 1 | 1996 | 1965 | 0.010 |
Why?
|
| Lipoproteins | 1 | 1994 | 880 | 0.000 |
Why?
|
| Glycosuria | 1 | 1986 | 44 | 0.000 |
Why?
|
| Lidocaine | 1 | 1989 | 546 | 0.000 |
Why?
|
| Breast Neoplasms | 1 | 1993 | 21188 | 0.000 |
Why?
|
| Multicenter Studies as Topic | 1 | 1990 | 1737 | 0.000 |
Why?
|
| Survival Rate | 1 | 1998 | 12873 | 0.000 |
Why?
|
| Linear Models | 1 | 1994 | 5891 | 0.000 |
Why?
|
| Eating | 1 | 1990 | 1542 | 0.000 |
Why?
|
| Sleep Deprivation | 1 | 1990 | 848 | 0.000 |
Why?
|